綠色科技

創造精彩未來

廣納人才

About Us

We trace our roots to Chung Nam Company, a sole proprietorship founded in 1935 by the late Mr. and Mrs. Chong Ching Um at Hong Kong. In 1980s, CN Innovations Holdings Limited (CN Innovations) originated from the metal department of Chung Nam Company to a leading innovative material science company offering effective technical and supply chain solutions to major industries. Products and services which we provide include Conventional Metal Processing & Precision Stamping, Metal Injection Molding, Window Display, Touch Panels and Decorative Coating together with Functional Coating business.Continuous investment in R&D is one of main reasons of our success. Apart from setting up R&D center in China, USA, UK, and Switzerland, we also cooperate with the University of Oxford and The Hong Kong University of Science & Technology on various R&D projects.

Our Headquarter locates at Hong Kong, and our main production sites spread across the Mainland China, including Shenzhen, Guangzhou, Suzhou, Zhejiang and Shanghai, employed with over 11,000 employees.

News

CN Bio Innovations marks World Hepatitis Day by signing research agreement with Imperial College London. July 2014

CN Bio Innovations marks World Hepatitis Day by signing

research agreement with Imperial College London

Collaboration will develop and further validate CN Bio's in vitro model of Hepatitis B liver infection

Oxford, UK, 28 July 2014: CN Bio Innovations Ltd (CN Bio), an expert in developing leading edge human biomimetic platforms to test and develop therapeutics for serious diseases, announced today that it has signed a research agreement with Imperial College London to advance the development of in vitro models of liver infection based on the company's LiverChip™ platform. The announcement coincides with the WHO World Hepatitis Day and serves to further emphasise the current efforts being forged by industry and academia to find cures for Hepatitis and other serious liver diseases.

Validation of in vitro system for liver infection

Dr Marcus Dorner, who is the Lead Principal Investigator on the new project at Imperial, commented: "Unfortunately, the liver models currently in widespread use often fail to accurately reproduce what we see in vivo, limiting their utility." He continued: "We're excited about the early potential shown by CN Bio's platform for studying the pathology of Hepatitis B and look forward to presenting our results from this ongoing program of work at a number of international conferences this Fall."

Forging enabling partnerships and alliances with Academia and Industry

Dr Emma Sceats, COO at CN Bio, said: "We are pleased to extend our relationship with Imperial through this new collaboration with Dr Dorner and Professor Mark Thursz. Forging partnerships with key opinion leaders and academic groups is a cornerstone of our research and development strategy whose goal is to bring to market biomimetic models that will provide unique insights into liver biology and disease pathology. Through alliance partnerships with major pharmaceutical and biotech companies, CN Bio's experts are using these models to accelerate the development of drugs that will provide life-changing treatment and cures for patients affected by serious liver diseases."

Early results from the collaboration are due to be presented at a number of conferences including the American Association for the Study of Liver Diseases (AASLD) meeting in Boston, November 7–11, 2014. For more details visit the CN Bio website:http://www.cn-bio.com/.

Green Mobility launched a range-extended electric vehicle for use in the Hong Kong market. December 2013

CN Bio began commercial sales of LiverChip. December 2012

Career

CN Innovations understand that human capital is the essential element of business growth and profitability, thus we are committed to provide employee with good working and living environment, competitive salary package and excellent career development platform, in order to develop and reinforce the valuable asset of the company. In respond to the rapid business growth, we organized graduate trainee program every year providing comprehensive training opportunities to fresh university graduate. In 2014, we initiated a national recruitment program and recruited over 100 university graduates from over 20 top tier universities in China.

The fast growing CN Innovations offer excellent career development opportunities to anyone who shares our corporate values. If you agree with us, please do not hesitate to join us!